Stallergenes - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Stallergenes. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Stallergenes. The Group's principal activity is to develop, produce and distribute immunotherapy solutions to treat allergies. The Group offers allergen extracts used to correct the immune imbalance. The Group supplies therapeutic products for diagnostic purpose as well as treatments. Under diagnostic purpose, the Group offers prick tests and vitro tests which help medical professionals to confirm the diagnosis. Under treatments, the Group offers subcutaneous injections, and sublingual drops. The Group operates mainly in France, Spain, Portugal, Italy, Greece and Switzerland.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report